Vanguard Personalized Indexing Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Vanguard Personalized Indexing Management, LLC

$6.09 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.28 - $1.16 $1,935 - $8,020	6,914 Added 22.95%	37,046 $12,000
Q1 2024 May 09, 2024	SELL	$1.06 - $1.67 $22,760 - $35,858	-21,472 Reduced 41.61%	30,132 $34,000
Q4 2023 Feb 07, 2024	SELL	$1.26 - $1.79 $36,843 - $52,341	-29,241 Reduced 36.17%	51,604 $87,000
Q3 2023 Nov 08, 2023	BUY	$1.61 - $2.54 $4,157 - $6,558	2,582 Added 3.3%	80,845 $146,000
Q2 2023 Jul 28, 2023	BUY	$1.14 - $1.95 $38,381 - $65,652	33,668 Added 75.5%	78,263 $145,000
Q1 2023 May 10, 2023	SELL	$1.2 - $2.19 $43,387 - $79,181	-36,156 Reduced 44.77%	44,595 $59,000
Q4 2022 Feb 10, 2023	SELL	$1.63 - $3.52 $52,096 - $112,502	-31,961 Reduced 28.36%	80,751 $136,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $25,488 - $130,585	34,916 Added 44.88%	112,712 $352,000
Q2 2022 Aug 09, 2022	SELL	$2.2 - $4.2 $120,210 - $229,492	-54,641 Reduced 41.26%	77,796 $185,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $273,287 - $839,175	96,568 Added 269.22%	132,437 $534,000
Q4 2021 Feb 23, 2022	BUY	$8.31 - $14.92 $298,071 - $535,165	35,869 New	35,869 $298,000

Others Institutions Holding DNA

# of Institutions

Shares Held

48.4M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

42M
Shares

$302 Million
0.0% of portfolio
Titleist Asset Management, Ltd. San Antonio, TX

2.31M
Shares

$16.6 Million
0.92% of portfolio
Putnam Investments LLC Boston, MA

1.5M
Shares

$10.8 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.15M
Shares

$8.23 Million
0.0% of portfolio
Benjamin F. Edwards & Company, Inc. St. Louis, MO

235K
Shares

$1.69 Million
0.0% of portfolio

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Account